Observed arrival · 2026-10-11
N1 Therapeutics’ canine vaccine workflow
A research project outlines a six-stage path toward personalized neoantigen vaccines, starting with canine oncology.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Veterinary oncology and vaccine-development collaborators
- Worth noticing
- The ranking section names DLA compatibility, mutant-expression evidence, and tumour relevance among five criteria for prioritizing experimental candidates.
Field notes
The page maps six handoffs, from veterinary suitability assessment and paired tumour/normal sample collection through sequencing, target ranking, validation, and vaccine formulation. Its ranking workflow lists five considerations, including DLA compatibility and mutant-expression evidence, while the roadmap is framed as moving from a hackathon prototype toward clinical validation.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central
One card from the complete issue